Anti-SARS-CoV-2 Antibodies versus Vaccination Status in CAD Patients with COVID-19: A Prospective, Propensity Score-Matched Cohort Study.

Sylvia Mink Heinz Drexel Andreas Leiherer Janne Cadamuro Wolfgang HitzlMatthias FrickPatrick ReimannChristoph H SaelyPeter Fraunberger

Published in: Vaccines (2024)

Antibody levels are a stronger predictor of outcome in CAD patients with COVID-19 than vaccination status, with 1200 BAU/mL being the more conservative threshold. Measuring anti-SARS-CoV-2 antibodies in CAD patients may ensure enhanced protection by providing timely booster vaccinations and identifying high-risk CAD patients at hospital admission.

Keyphrases

sars cov
coronary artery disease
end stage renal disease
respiratory syndrome coronavirus
ejection fraction
newly diagnosed
emergency department
chronic kidney disease
prognostic factors
patient reported outcomes
adverse drug